Skip to content

To evaluate the efficacy of Agnikarma with Madhuchista and Panchaloha Shalaka in the pain management of Janu Sandhigata Vata with special reference to Knee Osteoarthritis. ?

A Randomized Comparative Clinical trail to evaluate the efficacy of Agnikarma with Madhuchista and Panchaloha Shalaka in the pain management of Janu Sandhigata Vata with special reference to Knee Osteoarthritis. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070521
Enrollment
40
Registered
2024-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee Health Condition 2: M179- Osteoarthritis of knee, unspecified

Interventions

None listed

Sponsors

BVVS Ayurved Medical College and Hospital Bagalkot
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex and between age group of 30-70 years. 2. Subjects with signs and symptoms of Sandhigata Vata as per Ayurvedic classics. 3. Subjects fulfilling the diagnostic criteria and diagnosed previously as knee osteoarthritis. 4. Patients who are willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patient suffering from other than knee osteoarthritis. (Rheumatic heart disease, Rheumatoid arthritis ,Gouty arthritis,Osteoporosis and other Musculoskeletal system disorder). 2. Patient with other major systematic disorders which interfere with treatment will be excluded like uncontrolled Diabetes Mellitus (FBS >130mg/dl, PPBS >250 mg/dl, HbA1C >8.5%) and Hypertension >160/100 mm of hg. 3. Patient with congenital deformities –Genu varus, Genu valgus. 4. Pregnant women and lactating mother. 5. Patients contraindicated for Agnikarma as per classics.

Design outcomes

Primary

MeasureTime frame
Reduction in 1.Knee joint pain Timepoint: 7 days

Secondary

MeasureTime frame
Reduction in 1.Swelling 2.CrepitusTimepoint: 14 days

Countries

India

Contacts

Public ContactDr M S Hiremath

BVVS Ayurved Medical College and Hospital Bagalkot

dryogesh6@gmail.com9886664541

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026